301 related articles for article (PubMed ID: 30010625)
21. Oxidative stress induced by inactivation of TP53INP1 cooperates with KrasG12D to initiate and promote pancreatic carcinogenesis in the murine pancreas.
Al Saati T; Clerc P; Hanoun N; Peuget S; Lulka H; Gigoux V; Capilla F; Béluchon B; Couvelard A; Selves J; Buscail L; Carrier A; Dusetti N; Dufresne M
Am J Pathol; 2013 Jun; 182(6):1996-2004. PubMed ID: 23578383
[TBL] [Abstract][Full Text] [Related]
22. GRP78 haploinsufficiency suppresses acinar-to-ductal metaplasia, signaling, and mutant
Shen J; Ha DP; Zhu G; Rangel DF; Kobielak A; Gill PS; Groshen S; Dubeau L; Lee AS
Proc Natl Acad Sci U S A; 2017 May; 114(20):E4020-E4029. PubMed ID: 28461470
[TBL] [Abstract][Full Text] [Related]
23. Early requirement of Rac1 in a mouse model of pancreatic cancer.
Heid I; Lubeseder-Martellato C; Sipos B; Mazur PK; Lesina M; Schmid RM; Siveke JT
Gastroenterology; 2011 Aug; 141(2):719-30, 730.e1-7. PubMed ID: 21684285
[TBL] [Abstract][Full Text] [Related]
24. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
[TBL] [Abstract][Full Text] [Related]
25. Gli2 protein expression level is a feasible marker of ligand-dependent hedgehog activation in pancreatic neoplasms.
Sugiyama Y; Sasajima J; Mizukami Y; Koizumi K; Kawamoto T; Ono Y; Karasaki H; Tanabe H; Fujiya M; Kohgo Y
Pol J Pathol; 2016 Jun; 67(2):136-44. PubMed ID: 27543868
[TBL] [Abstract][Full Text] [Related]
26. The biological features of PanIN initiated from oncogenic Kras mutation in genetically engineered mouse models.
Shen R; Wang Q; Cheng S; Liu T; Jiang H; Zhu J; Wu Y; Wang L
Cancer Lett; 2013 Oct; 339(1):135-43. PubMed ID: 23887057
[TBL] [Abstract][Full Text] [Related]
27. BRCA2 dysfunction promotes malignant transformation of pancreatic intraepithelial neoplasia.
Wang Q; Liu H; Liu T; Shu S; Jiang H; Cheng S; Yuan Y; Yang W; Wang L
Anticancer Agents Med Chem; 2013 Feb; 13(2):261-9. PubMed ID: 22934697
[TBL] [Abstract][Full Text] [Related]
28. SOX9 inhibits β-TrCP-mediated protein degradation to promote nuclear GLI1 expression and cancer stem cell properties.
Deng W; Vanderbilt DB; Lin CC; Martin KH; Brundage KM; Ruppert JM
J Cell Sci; 2015 Mar; 128(6):1123-38. PubMed ID: 25632159
[TBL] [Abstract][Full Text] [Related]
29. Ciliogenesis and Hedgehog signalling are suppressed downstream of KRAS during acinar-ductal metaplasia in mouse.
Bangs FK; Miller P; O'Neill E
Dis Model Mech; 2020 Jul; 13(7):. PubMed ID: 32571902
[TBL] [Abstract][Full Text] [Related]
30. hsa-miR-96 and hsa-miR-217 Expression Down-Regulates with Increasing Dysplasia in Pancreatic Intraepithelial Neoplasias and Intraductal Papillary Mucinous Neoplasms.
Chang X; Yu C; Li J; Yu S; Chen J
Int J Med Sci; 2017; 14(5):412-418. PubMed ID: 28539816
[No Abstract] [Full Text] [Related]
31. Role of the ductal transcription factors HNF6 and Sox9 in pancreatic acinar-to-ductal metaplasia.
Prévot PP; Simion A; Grimont A; Colletti M; Khalaileh A; Van den Steen G; Sempoux C; Xu X; Roelants V; Hald J; Bertrand L; Heimberg H; Konieczny SF; Dor Y; Lemaigre FP; Jacquemin P
Gut; 2012 Dec; 61(12):1723-32. PubMed ID: 22271799
[TBL] [Abstract][Full Text] [Related]
32. Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.
Qiu W; Tang SM; Lee S; Turk AT; Sireci AN; Qiu A; Rose C; Xie C; Kitajewski J; Wen HJ; Crawford HC; Sims PA; Hruban RH; Remotti HE; Su GH
Gastroenterology; 2016 Jan; 150(1):218-228.e12. PubMed ID: 26408346
[TBL] [Abstract][Full Text] [Related]
33. Where and when does pancreatic carcinoma start?
Lüttges J; Hahn S; Klöppel G
Med Klin (Munich); 2004 Apr; 99(4):191-5. PubMed ID: 15085289
[TBL] [Abstract][Full Text] [Related]
34. Organoid-based ex vivo reconstitution of Kras-driven pancreatic ductal carcinogenesis.
Matsuura T; Maru Y; Izumiya M; Hoshi D; Kato S; Ochiai M; Hori M; Yamamoto S; Tatsuno K; Imai T; Aburatani H; Nakajima A; Hippo Y
Carcinogenesis; 2020 Jun; 41(4):490-501. PubMed ID: 31233118
[TBL] [Abstract][Full Text] [Related]
35. Nardilysin inhibits pancreatitis and suppresses pancreatic ductal adenocarcinoma initiation in mice.
Ikuta K; Fukuda A; Ogawa S; Masuo K; Goto N; Hiramatsu Y; Tsuda M; Kimura Y; Matsumoto Y; Kimura Y; Maruno T; Kanda K; Nishi K; Takaori K; Uemoto S; Takaishi S; Chiba T; Nishi E; Seno H
Gut; 2019 May; 68(5):882-892. PubMed ID: 29798841
[TBL] [Abstract][Full Text] [Related]
36. Mutant GNAS drives pancreatic tumourigenesis by inducing PKA-mediated SIK suppression and reprogramming lipid metabolism.
Patra KC; Kato Y; Mizukami Y; Widholz S; Boukhali M; Revenco I; Grossman EA; Ji F; Sadreyev RI; Liss AS; Screaton RA; Sakamoto K; Ryan DP; Mino-Kenudson M; Castillo CF; Nomura DK; Haas W; Bardeesy N
Nat Cell Biol; 2018 Jul; 20(7):811-822. PubMed ID: 29941929
[TBL] [Abstract][Full Text] [Related]
37. SWI/SNF component
Wang SC; Nassour I; Xiao S; Zhang S; Luo X; Lee J; Li L; Sun X; Nguyen LH; Chuang JC; Peng L; Daigle S; Shen J; Zhu H
Gut; 2019 Jul; 68(7):1259-1270. PubMed ID: 30315093
[TBL] [Abstract][Full Text] [Related]
38. Polycomb repressor complex 1 promotes gene silencing through H2AK119 mono-ubiquitination in acinar-to-ductal metaplasia and pancreatic cancer cells.
Benitz S; Regel I; Reinhard T; Popp A; Schäffer I; Raulefs S; Kong B; Esposito I; Michalski CW; Kleeff J
Oncotarget; 2016 Mar; 7(10):11424-33. PubMed ID: 26716510
[TBL] [Abstract][Full Text] [Related]
39. A genetically engineered mouse model developing rapid progressive pancreatic ductal adenocarcinoma.
Yamaguchi T; Ikehara S; Nakanishi H; Ikehara Y
J Pathol; 2014 Oct; 234(2):228-38. PubMed ID: 25042889
[TBL] [Abstract][Full Text] [Related]
40. Loss of the acinar-restricted transcription factor Mist1 accelerates Kras-induced pancreatic intraepithelial neoplasia.
Shi G; Zhu L; Sun Y; Bettencourt R; Damsz B; Hruban RH; Konieczny SF
Gastroenterology; 2009 Apr; 136(4):1368-78. PubMed ID: 19249398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
